Except for the cell-autonomous effects of CLPTM1L on the resistance, they also found CLPTM1L from exosomes conferred chemo-resistance to bystander ovarian cancer cells in an ectodomain-dependent manner. The gene discussed is CLPTM1L; the disease is ovarian cancer.